|
NUP93 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
7.99360577730113E-15 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.057000E-03 |
| Stage1-vs-Stage3 |
9.567200E-01 |
| Stage1-vs-Stage4 |
6.261500E-03 |
| Stage2-vs-Stage3 |
1.173760E-02 |
| Stage2-vs-Stage4 |
6.042800E-01 |
| Stage3-vs-Stage4 |
3.148300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.622300E-04 |
| Normal-vs-Asian |
9.37810051837573E-10 |
| Caucasian-vs-AfricanAmerican |
2.743600E-01 |
| Caucasian-vs-Asian |
2.385400E-01 |
| AfricanAmerican-vs-Asian |
5.935400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
8.252600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
8.07360000000257E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.922400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.342100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.619600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.718300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.651000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.273000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.593800E-01 |
| Classical-VS-Follicular |
9.97069999897349E-08 |
| Classical-VS-Other |
7.126200E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
3.481600E-03 |
| Tall-VS-Other |
8.842200E-01 |
| Tall-VS-Normal |
8.61721805023308E-12 |
| Follicular-VS-Other |
1.918610E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
2.644400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
5.08482145278322E-14 |
| N0-vs-N1 |
7.964800E-01 |
|
|
